| 期 |
标题 |
文件 |
| 卷 9, 编号 2 (2023) |
Evaluation of the efficacy of probiotic medicines including in the therapy of patients with post-infectious irritable bowel syndrome after COVID-19 infection surviving |
|
|
Didigova R., Evloeva D., Ugurchieva P., Malsagova I., Khamkhoeva F., Bokova M.
|
| 卷 10, 编号 3 (2024) |
In memory of Galina Nikolaevna Gorokhovskaya (1935–2024) |
|
|
Editorial B.
|
| 卷 9, 编号 6 (2023) |
Pathogenetic therapy of pulmonary hypertension |
|
|
Tsareva N., Khachaturov M., Avdeev S.
|
| 卷 9, 编号 2 (2023) |
Pathogenetic therapy in case of COVID-19: decreasing of key hyper inflammatory response factors production |
|
|
Nikolaeva S.
|
| 卷 9, 编号 6 (2023) |
Patient-oriented approach in the choice of treatment strategy in internal diseases clinic |
|
|
Verushkina A., Efremova E.
|
| 卷 9, 编号 6 (2023) |
Based on materials of community-acquired pneumonia – an European Federation of internal medicine guideline critical appraisal adaptation for internists: important answers to difficult questions |
|
|
Kokorin V., Larina V., Lunev D., Suvorova N.
|
| 卷 9, 编号 6 (2023) |
Injuries of thoracic cage |
|
|
Zaitsev A., Davydov D., Chuprina A., Sergoventsev A., Malyavin A.
|
| 卷 9, 编号 8 (2023) |
Indexes of left ventricle contractive function in persons after acute coronary event, depending on the presence of diabetes mellitus and sodium-glucose transporter inhibitors type 2 use |
|
|
Nevzorova V., Semenova P., Zakharchuk N., Ivina A.
|
| 卷 9, 编号 6 (2023) |
Lung damage in rheumatoid arthritis: complex points of clinical practice |
|
|
Beketova M., Georginova O., Krasnova T.
|
| 卷 9, 编号 1 (2023) |
Predictors of cardiovacular risk as prognostic factors of adverse course and outcomes of COVID-19 in young and middle age adults |
|
|
Bratilova E., Kachnov V., Tyrenko V., Afonaskov O.
|
| 卷 10, 编号 3 (2024) |
Predictors of creatininemia in locomotive crew workers: Prospective observational study |
|
|
Lazutkina A.
|
| 卷 10, 编号 5 (2024) |
Benefits and problems of physical activity during the COVID-19 pandemic |
|
|
Grigor’eva I.
|
| 卷 9, 编号 8 (2023) |
Use of Canephron® N for symptoms of acute cystitis in female patients with type 2 diabetes mellitus taking sodium-glucose cotransporter-2 inhibitors |
|
|
Malyavin A., Gubernatorova E., Babak S.
|
| 卷 9, 编号 2 (2023) |
Use of magnesium and sulfates-enriched natural mineral water in case of functional constipations in adult and pediatric patients |
|
|
Mubarakshina O., Batishcheva G., Shcherbova Z.
|
| 卷 10, 编号 3 (2024) |
Use of erenumab in real clinical practice |
|
|
Berdnikova A., Kadymova N., Latysheva N., Naprienko M., Filatova E.
|
| 卷 9, 编号 6 (2023) |
Propafenone or sotalol? Choice of antiarrhythmic drug in real clinical practice |
|
|
Syrov A.
|
| 卷 9, 编号 1 (2023) |
Anti-inflammatory therapy of joint syndrome in an outpatient practitioner |
|
|
Kudina E., Samkova I.
|
| 卷 9, 编号 1 (2023) |
Soluble suppression of tumorigenicity 2 (sST2) as a predictor of adverse outcomes of chronic heart failure |
|
|
Kravchenko A., Budnevsky A., Chernik T., Tokmachev R.
|
| 卷 9, 编号 1 (2023) |
Resolution of the expert council «Vitamin B12 deficiency in clinical practice» |
|
|
Bolieva L., Bolotina L., Galstyan G., Drapkina O., Ekusheva E., Kaprin A., Lukina E., Malyavin A., Martynov A., Ponomaryov R., Suponeva N., Tarasova L.
|
| 卷 10, 编号 5 (2024) |
Resolution of the experts’ council “perspective possibilities of using GRS drug in therapeutic practice” |
|
|
Martynov A., Barbarash O., Kobalava Z., Malyavin A., Boshchenko A., Vengerovskii A., Zateyshchikov D., Chesnikova A., Yakushin S., Kashtalap V., Khazanov V., Bykov V., Larchenkо V.
|
| 卷 9, 编号 2 (2023) |
Resolution of the expert council on the use of herbal medicines for respiratory infections |
|
|
Board E.
|
| 卷 9, 编号 2 (2023) |
Review of the teaching guide for doctors «Duplex scanning of extracranial parts of the brachiocephalic arteries and veins» |
|
|
Martynov A.
|
| 卷 10, 编号 4 (2024) |
Role of myocardial bridgings in acute coronary syndrome genesis in patients under 65 years old |
|
|
Izmozherova N., Dmitriev V., Bakhtin V., Popov A.
|
| 卷 10, 编号 4 (2024) |
The role of potable curative mineral water in digestive system functions maintaining |
|
|
Mubarakshina O., Dronova Y., Chernov S.
|
| 卷 10, 编号 4 (2024) |
Pericardial sarcoma: difficulties in diagnostic search |
|
|
Tatarintseva Z., Palshkova A., Barbuhatti K., Babicheva O.
|
| 卷 10, 编号 5 (2024) |
Association between diabetes mellitus and lower respiratory tract and pulmonary diseases: scientific discussion |
|
|
Babak S., Gorbunova M., Gubernatorova E., Malyavin A.
|
| 卷 10, 编号 4 (2024) |
Correlation between low density lipoproteins / high density lipoproteins ratio and new-onset atrial fibrillation after coronary artery bypass grafting |
|
|
Tatarintseva Z., Kosmachova E.
|
| 卷 10, 编号 3 (2024) |
Gilbert’s syndrome concerning a new look at the effects of hyperbilirubinemia |
|
|
Gerasimenko I., Morozov N., Gerasimenko A.
|
| 卷 10, 编号 3 (2024) |
Irritable bowel syndrome in new clinical practice |
|
|
Maev I., Osadchuk M., Osadchuk A.
|
| 卷 9, 编号 8 (2023) |
Modern aspects of the use of acetylsalicylic acid in pregnant women |
|
|
Chulkov V., Nikolenko E., Chulkov V., Okonenko T., Zhmaylova S.
|
| 卷 9, 编号 2 (2023) |
Modern aspects of the use of local hyaluronic acid in musculoskeletal diseases |
|
|
Strebkova E., Alekseeva L.
|
| 卷 9, 编号 8 (2023) |
Modern aspects of use of tirzepatide – the first dual agonist of glucagon-like peptide-1 and glucosependent insulinotropic peptide receptors |
|
|
Usanova A., Lavrenova E., Kunyaeva T., Kuzma F., Novikova E., Sergutova N., Chatkina T.
|
| 卷 9, 编号 8 (2023) |
Modern approaches to colorectal cancer screening and prevention |
|
|
Bakulin I., Zharkov A., Serkova M., Zhuravleva M.
|
| 卷 9, 编号 6 (2023) |
Expert consensus on the issues of urinary incontinence in elderly and senile patients |
|
|
Drapkina O., Adamyan L., Shamalov N., Pushkar D., Tkacheva O.
|
| 卷 9, 编号 1 (2023) |
Comparative analysis of efficacy and safety of different medicines containing celecoxib in patients with knee osteoarthritis |
|
|
Trofimov E., Mazurov V., Bashkinov R., Trofimova A., Gaydukova I.
|
| 卷 9, 编号 1 (2023) |
Therapy of osteoarthritis in combination with assymptomatic hyperuricemia: results of a pilot study |
|
|
Mazurov V., Bashkinov R., Inamova O., Petrova M., Morozova K.
|
| 卷 9, 编号 2 (2023) |
Course of COVID-19-associated pneumonia in patients vaccinated against COVID-19 |
|
|
Lysenko M., Poteshkina N., Ibragimova A., Krylova N., Kovalevskaya E., Karasev A., Svanadze A.
|
| 卷 10, 编号 3 (2024) |
Difficulties of curation of a patient with irritable bowel syndrome |
|
|
Busalaeva E., Tarasova L.
|
| 卷 9, 编号 2 (2023) |
Dear Colleagues! |
|
|
Editorial B.
|
| 卷 10, 编号 4 (2024) |
Shock wave therapy: possibilities and perspectives for application in clinical practice for diabetic foot patients |
|
|
Teltevskaya I., Ivanova S., Yushchuk E., Mkrtumyan A., Melekhina I.
|
| 卷 9, 编号 6 (2023) |
Enhanced external counterpulsation as a measure of non-drug treatment of patients with severe and moderate ventilation disorders |
|
|
Nikolaeva N., Belenkov Y., Lishuta A., Voronkova O., Rogova E., Buyanova O., Abdullaeva G.
|
| 卷 10, 编号 5 (2024) |
Risk factors of brain stroke, specific for female individuals |
|
|
Maksimova M., Ayrapetova A.
|
| 卷 10, 编号 5 (2024) |
Febuxostat: efficacy and safety of the drug, prospects for application (literature review) |
|
|
Shchemeleva E., Skorodumova E.
|
| 卷 9, 编号 6 (2023) |
Federal clinical recommendations for sarcoidosis diagnosis and treatment: accents and comments |
|
|
Vizel A., Avdeev S., Malyavin A., Shmelev E., Vizel I.
|
| 卷 9, 编号 8 (2023) |
Fixed combination of levocetirizine and montelukast in the treatment of allergic rhinitis |
|
|
Bolieva L., Moulid A., Basieva A.
|
| 卷 10, 编号 3 (2024) |
Chemopreventive and anti-tumor potential of ademetionine in case of chronic hepatic disorders |
|
|
Prikhodko V., Okovityi S.
|
| 卷 9, 编号 2 (2023) |
Chronic ebv infection in clinical practice: what should be considered when diagnosing |
|
|
Nikolskiy M., Lioznov D., Malyavin A.
|
| 卷 10, 编号 4 (2024) |
Chronic prostatitis. Clinical lecture No. 2: diagnostics and therapy |
|
|
Borisov V.
|
| 卷 10, 编号 4 (2024) |
Incidence degree and clinical significance of first detected hypothyroidia in patients with ST-segment elevation myocardial infarction |
|
|
Gridneva Y., Chesnikova A., Safronenko V., Edlenko E., Zatloukal M.
|
| 卷 9, 编号 2 (2023) |
Expression of innate immunity TLR3 and TLR7 receptors at the level of the upper respiratory airways’ mucosa in patients with severe COVID-19 |
|
|
Abramova N., Soshchenko T., Meremyanina E., Solntseva V., Zheleznyak V., Svitich O.
|
| 卷 10, 编号 3 (2024) |
Extragastral clinical manifestations in patients with chronic atrophic gastritis |
|
|
Bakulin I., Sushilova A., Zharkov A.
|
| 卷 10, 编号 4 (2024) |
Elastic moments of arteries in patients with chronic heart failure: visceral obesity influence |
|
|
Statsenko M., Derevyanchenko M., Fabritskaya S., Shilina N.
|
| 卷 10, 编号 5 (2024) |
Wernicke encephalopathy of non-alcoholic genesis |
|
|
Ostapchuk E., Chikviladze S.
|
| 卷 10, 编号 4 (2024) |
Efficacy and safety of ebastine use in patients having chronic spontaneous urticaria |
|
|
Bolieva L., Tseboeva M.
|
| 卷 10, 编号 3 (2024) |
Efficacy of use of Enerion (sulbuthiamine) in asthenia treatment in patients having chronic non-infectious diseases in outpatient practice |
|
|
Shimokhina N., Petrova M., Bychkovskaya M.
|
| 101 - 155 的 155 信息 |
<< < 1 2 |
